Innovative Medicines Initiative (IMI) announces funding of €72m for COVID projects

On 3 March 2020, the Innovative Medicines Initiative (IMI) supported through the Horizon 2020 Framework Programme  launched a special fast-track call for the “Development of therapeutics and diagnostics combatting coronavirus infections” with an EU contribution of €45 million, which was subsequently increased to €72 million.

The European Commission has announced the short-listing of 8 applications. The UK are involved in 6 of these, leading two of the collaborations. Full details of these collaborations will be announced shortly.

Of the eight projects, five focus on diagnostics and three on treatments. 

  • Diagnostic tests: the 5 projects on diagnostics aim to develop devices that can be used anywhere and will deliver results very quickly, enabling front-line health workers to make the diagnosis more quickly and more accurately, which will in turn reduce the risk of further spread of the virus. 
  • New treatments: the 3 projects on therapies address primarily the current COVID-19 outbreak, but also foresee efforts to prepare for future coronavirus outbreaks.

The Projects are:


  • COVID-RED: COVID-19 infections - remote early detection
  • DECISION: A miniaturised disposable molecular diagnostics platform for combatting coronavirus infections 
  • DRAGON: Rapid and secure AI imaging based diagnosis, stratification, follow-up, and preparedness for coronavirus pandemics
  • KRONO:Evaluation of a production ready portable, point-of-need platform, direct from nasal swab test for the molecular diagnostic detection of COVID-19
  • RAPID-COVI: Robust automation and point of care identification of COVID


  • CARE: Corona accelerated R&D in Europe
  • Impentri: Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)
  • MAD-CoV 2: Modern approaches for developing antivirals against SARS-CoV 2 

Further Information is available on:

IMI Website

Read the press release from the European Commission

Information on IMI2 – Call 21 on the coronavirus

Factsheet on the new projects

Information on other IMI projects’ contributions to coronavirus research

The European Commission's global response to the coronavirus 

EFPIA's contribution to the fight against COVID-19

Richard Buxbaum
SME Innovation
Health, Well-being and Life Sciences